Advanced Development of Medical Countermeasures for Infectious Diseases

NIH RePORTER · NIH · N01 · $4,300,537 · view on reporter.nih.gov ↗

Abstract

To support the advanced development of a promising candidate therapeutic. The research and development activities to be supported will allow the candidate therapeutic product to progress along the product development pathway, and include preclinical and IND enabling development activities, and clinical safety and efficacy assessment.

Key facts

NIH application ID: 10929920
Project number: 75N93019C00057-P00009-9999-1
Recipient: NANOTHERAPEUTICS, INC.
Principal Investigator: MILAN TOMIC
Activity code: N01
Funding institute: NIH
Fiscal year: 2023
Award amount: $4,300,537
Award type: —
Project period: 2019-09-09 → 2024-08-11